Circulating LIGHT (TNFSF14) and Interleukin-18 Levels in Sepsis-Induced Multi-Organ Injuries
The novel therapeutic target cytokine LIGHT (TNFSF14) was recently shown to play a major role in COVID-19-induced acute respiratory distress syndrome (ARDS). This study aims to investigate the associations of plasma LIGHT and another potentially targetable cytokine, interleukin-18 (IL-18), with ARDS...
Main Authors: | Hui-Qi Qu, James Snyder, John Connolly, Joseph Glessner, Charlly Kao, Patrick Sleiman, Hakon Hakonarson |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/2/264 |
Similar Items
-
Surviving Sepsis Campaign COVID-19 Panel
by: Yu.Yu. Kobelyatskyy, et al.
Published: (2022-06-01) -
Pulmonary Microbial Composition in Sepsis-Induced Acute Respiratory Distress Syndrome
by: Peng Zhang, et al.
Published: (2022-06-01) -
Corticosteroids in ARDS
by: Emmanuelle Kuperminc, et al.
Published: (2023-05-01) -
Deep Learning Chest CT for Clinically Precise Prediction of Sepsis-Induced Acute Respiratory Distress Syndrome: A Protocol for an Observational Ambispective Cohort Study
by: Han Li, et al.
Published: (2022-10-01) -
A diagnostic model for sepsis-induced acute lung injury using a consensus machine learning approach and its therapeutic implications
by: Yongxin Zheng, et al.
Published: (2023-09-01)